2013World Clinical DrugsRequires access

Studies on pharmacokinetics of two long-acting triptorelin injections in Beagle dogs

GE Qing-hua

Open publisher page 0 citations

Abstract

Objective To study pharmacokinetics of two long-acting triptorelin injections(Decapeptyl 3.75 mg and Diphereline 3.75 mg) in male Beagle dogs.Methods A tatal of 10 healthy male Beagle dogs were randomly divided into two groups.The plasma concentration of triptorelin was determained by a validated LC-MS/MS method after intramuscular injection of the two injections.The pharmacokinetic parameters were calculated by DAS 3.2.2.Results The mean pharmacokinetic parameters were as follows: Cmax(11.95±2.127) and(27.93±8.752) ng/mL,Tmax(1.2±0.4) and(0.7 ±0.3) h,T1/2(244.7±99.25) and(239.6±87.50) h,AUC(0-t)(758.8±111.9) and(492.3±125.9)ng h mL-1,AUC(0-)(778.9± 101.3)and(515.6±125.3) ng h mL-1,respectively for Decapeptyl and Diphereline.Conclusion The Cmax、AUC(0-) and AUC(0-t)of Diphereline and Decapeptyl in Beagle dogs were different significantly.These two injections could keep the plasma concentration above the LLOQ for more than 28 days.

About this research paper

What this paper is about

Objective To study pharmacokinetics of two long-acting triptorelin injections(Decapeptyl 3.75 mg and Diphereline 3.75 mg) in male Beagle dogs.Methods A tatal of 10 healthy male Beagle dogs were randomly divided into two groups.The plasma concentration of triptorelin was determained by a validated LC-MS/MS method after intramuscular injection of the two injections.The pharmacokinetic parameters were calculated by DAS 3.2.2.Results The mean pharmacokinetic parameters were as follows: Cmax(11.95±2.127) and(27.93±8.752) ng/mL,Tmax(1.2±0.4) and(0.7 ±0.3) h,T1/2(244.7±99.25) and(239.6±87.50) h,AUC(0-t)(758.8±111.9) and(492.3±125.9)ng h mL-1,AUC(0-)(778.9± 101.3)and(515.6±125.3) ng h mL-1,respectively for Decapeptyl and Diphereline.Conclusion The Cmax、AUC(0-) and AUC(0-t)of Diphereline and Decapeptyl in Beagle dogs were different significantly.These two injections could keep the plasma concentration above the LLOQ for more than 28 days.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study pharmacokinetics of two long-acting triptorelin injections(Decapeptyl 3.75 mg and Diphereline 3.75 mg) in male Beagle dogs.Methods A tatal of 10 healthy male Beagle dogs were randomly divided into two groups.The plasma concentration of triptorelin was determained by a validated LC-MS/MS method after intramuscular injection of the two injections.The pharmacokinetic parameters were calculated by DAS 3.2.2.Results The mean pharmacokinetic parameters were as follows: Cmax(11.95±2.127) and(27.93±8.752) ng/mL,Tmax(1.2±0.4) and(0.7 ±0.3) h,T1/2(244.7±99.25) and(239.6±87.50) h,AUC(0-t)(758.8±111.9) and(492.3±125.9)ng h mL-1,AUC(0-)(778.9± 101.3)and(515.6±125.3) ng h mL-1,respectively for Decapeptyl and Diphereline.Conclusion The Cmax、AUC(0-) and AUC(0-t)of Diphereline and Decapeptyl in Beagle dogs were different significantly.These two injections could keep the plasma concentration above the LLOQ for more than 28 days.

Key concepts: Beagle, Pharmacokinetics, Cmax, Medicine, Triptorelin, Plasma concentration, Pharmacology, Bioavailability

Related papers

Back to paper searchBrowse research topicsOriginal source
Studies on pharmacokinetics of two long-acting triptorelin injections in Beagle dogs — Research Paper | ScholarLens